Twitter | Search | |
Medical Meeting News
The Leading News Source at Healthcare and Medical Meetings
843
Tweets
127
Following
191
Followers
Tweets
Medical Meeting News retweeted
ASAE Annual Meeting Apr 16
Brad Paisley and Peyton Manning are welcoming you to in style. The closing celebration will feature Brad Paisley and is exclusive to ASAE Annual Meeting attendees. See you there!
Reply Retweet Like
Medical Meeting News retweeted
ASAE Annual Meeting Jun 27
The concert of a lifetime awaits at The Classic with John Legend! Get your ticket when you register for ASAE Annual Meeting! Already registered? Don't fret, you can still add a ticket to your registration.
Reply Retweet Like
Medical Meeting News Jul 11
Reply Retweet Like
Medical Meeting News Jul 10
supplementation did not significantly lower the risk of compared to placebo, according to the results of the presented at
Reply Retweet Like
Medical Meeting News Jul 9
TODAY2 Study results reported at show that youth-onset is more aggressive than adult-onset disease
Reply Retweet Like
Medical Meeting News Jul 8
Results from the PREVIEW study comparing the benefits of 2 diet and 2 weight management programs showed comparable rates of delay toward in patients with prediabetes who had initially lost weight on a low-calorie diet
Reply Retweet Like
Medical Meeting News Jul 2
Researchers presented results from four recent and ongoing studies from the network at
Reply Retweet Like
Medical Meeting News Jul 1
Results from the RISE Clinical Trial presented at showed no long-term improvement in beta-cell function from various diabetes treatments, according to Steven E. Kahn, MB, ChB
Reply Retweet Like
Medical Meeting News Jun 28
DECLARE-TIMI 58 trial results presented at suggest that the SGLT2 inhibitor dapagliflozin reduces insulin resistance and CV risk factors, and also prevents and progression of in most patients
Reply Retweet Like
Medical Meeting News Jun 27
Dulaglutide, an injectable GLP-1 receptor agonist, can be considered for primary and secondary CV prevention in middle-aged & older patients with and CV risk factors, according to REWIND trial results reported at
Reply Retweet Like
Medical Meeting News Jun 26
In a comparison of linagliptin, a DPP-4 inhibitor, and glimepiride, a sulfonylurea, researchers found no difference in risk for CV mortality or overall mortality in patients, according to Julio Rosenstock, MD
Reply Retweet Like
Medical Meeting News Jun 25
When added to usual care in patients at increased risk of CV and/or renal disease, the DPP-4 inhibitor linagliptin resulted in CV and renal events comparable to placebo, according to CARMELINA results presented at
Reply Retweet Like
Medical Meeting News Jun 25
For patients with and , the SGLT2 inhibitor canagliflozin has a renal and CV protective effect in reducing the progression of kidney impairment, according to CREDENCE trial results presented at
Reply Retweet Like
Medical Meeting News Jun 24
PIONEER 6 trial results presented at suggest that oral semaglutide is safe for patients with at high CV risk
Reply Retweet Like
Medical Meeting News retweeted
ADA DiabetesPro Jun 17
After data analysis over a 2-year period, DiRECT clinical trial finds insulin-producing beta cells are not irreversibly lost in early stages of but can be restored through weight loss & minimizing weight regain.
Reply Retweet Like
Medical Meeting News retweeted
ADA DiabetesPro Jun 17
Dulaglutide, an injectable GLP-1 receptor agonist, reduces CVD in people w/ according to REWIND results presented at . REWIND is the first study to include a majority of participants with no history of CVD at enrollment. Learn more:
Reply Retweet Like
Medical Meeting News Jun 11
The Diabetes Technology Special Interest Group addressed some of the challenges clinicians face when choosing, prescribing, and assisting patients with medical devices at
Reply Retweet Like
Medical Meeting News Jun 11
The / Symposium at posed the question: Is in pediatric ready for prime time? The answer is a resounding YES, according to David M. Maahs, MD, PhD
Reply Retweet Like
Medical Meeting News retweeted
Niina Sandholm Jun 11
If you missed our ADA session, read how genetics and epigenetics affect diabetic complications!
Reply Retweet Like
Medical Meeting News Jun 11
At , and Howard Berger, MD, debated whether all pregnant women with or preexisting should be induced by 38 weeks
Reply Retweet Like